Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Bionano Genomics, Inc | bngo-ex322x20201231.htm |
| EX-32.1 - EX-32.1 - Bionano Genomics, Inc | bngo-ex321x20201231.htm |
| EX-31.2 - EX-31.2 - Bionano Genomics, Inc | bngo-ex312x20201231.htm |
| EX-31.1 - EX-31.1 - Bionano Genomics, Inc | bngo-ex311x20201231.htm |
| EX-23.2 - EX-23.2 - Bionano Genomics, Inc | consentsec325-exbx1x10xk.htm |
| EX-10.44 - EX-10.44 - Bionano Genomics, Inc | exhibit1044-innovatusxfour.htm |
| EX-10.23 - EX-10.23 - Bionano Genomics, Inc | ex1023-fourthamendmenttoir.htm |
| EX-10.22 - EX-10.22 - Bionano Genomics, Inc | ex1022-thirdamendmenttoirv.htm |
| EX-4.10 - EX-4.10 - Bionano Genomics, Inc | ex410-descriptionofsecurit.htm |
| EX-3.1 - EX-3.1 - Bionano Genomics, Inc | ex31-arcertificateofincorp.htm |
| 10-K - 10-K - Bionano Genomics, Inc | bngo-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-237070, 333-239360, 333-245762, 333-251956 and 333-252216) and Form S-8 (File Nos. 333-227073, 333-230589, 333-237069, 333-245764 and 333-248468) of our report dated March 23, 2021, relating to the consolidated financial statements of Bionano Genomics, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ BDO USA, LLP
San Diego, California
March 23, 2021